Mark Morales

726 total citations
21 papers, 555 citations indexed

About

Mark Morales is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Morales has authored 21 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Morales's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Mark Morales is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Mark Morales collaborates with scholars based in United States, Canada and Russia. Mark Morales's co-authors include Stephen H. Wright, Carlotta E. Groves, Sean Ekins, Eugene A. Mash, Akihito Hattori, Antonio J. Pérez‐Pulido, Sharon M. Dial, Ronald E. Allen, Ryuichi Tatsumi and Yoshihide Ikeuchi and has published in prestigious journals such as The FASEB Journal, Journal of the American Society of Nephrology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mark Morales

19 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Morales United States 12 217 213 123 85 64 21 555
Fen Zhou China 13 172 0.8× 120 0.6× 104 0.8× 29 0.3× 101 1.6× 36 727
Pei Hu China 15 330 1.5× 53 0.2× 64 0.5× 40 0.5× 50 0.8× 38 716
Anne Wu United States 13 206 0.9× 78 0.4× 84 0.7× 79 0.9× 79 1.2× 19 651
Zhu Zhou United States 13 106 0.5× 124 0.6× 65 0.5× 28 0.3× 25 0.4× 34 513
Vladimír Semecký Czechia 16 167 0.8× 138 0.6× 123 1.0× 93 1.1× 65 1.0× 39 790
Rucha Patel Canada 11 268 1.2× 80 0.4× 28 0.2× 108 1.3× 143 2.2× 16 640
Caroline Hild Hakvåg Pettersen Norway 8 126 0.6× 106 0.5× 57 0.5× 41 0.5× 211 3.3× 12 502
Salvatore Longo Italy 14 260 1.2× 96 0.5× 41 0.3× 59 0.7× 93 1.5× 30 753
Lisa Tee Australia 20 325 1.5× 128 0.6× 76 0.6× 132 1.6× 46 0.7× 48 1.1k
J. R. Snyman South Africa 12 126 0.6× 58 0.3× 36 0.3× 56 0.7× 67 1.0× 50 510

Countries citing papers authored by Mark Morales

Since Specialization
Citations

This map shows the geographic impact of Mark Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Morales more than expected).

Fields of papers citing papers by Mark Morales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Morales. The network helps show where Mark Morales may publish in the future.

Co-authorship network of co-authors of Mark Morales

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Morales. A scholar is included among the top collaborators of Mark Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Morales. Mark Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morales, Mark, et al.. (2022). Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease. American Journal of Physiology-Renal Physiology. 322(6). F680–F691. 9 indexed citations
3.
Lynch, Kevin G., et al.. (2021). Varenicline for the Treatment of Cocaine Dependence. Journal of Addiction Medicine. 16(2). 157–163. 2 indexed citations
4.
Jilek, Joseph L., et al.. (2020). Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2. Drug Metabolism and Disposition. 48(7). 603–612. 17 indexed citations
5.
Morales, Mark, et al.. (2019). Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2. American Journal of Physiology-Renal Physiology. 317(3). F720–F734. 9 indexed citations
6.
Morales, Mark, et al.. (2019). Cell Model for Studying Nucleoside Transporters, a Key Component of the Blood‐Testis Barrier. The FASEB Journal. 33(S1). 2 indexed citations
7.
8.
Morales, Mark, E. Paul Wileyto, Larry W. Hawk, et al.. (2017). Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors. 75. 122–129. 31 indexed citations
9.
Morales, Mark, et al.. (2016). Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1. Molecular Pharmacology. 90(3). 254–264. 20 indexed citations
10.
Shibayama, Takahiro, Mark Morales, Xiao­hong Zhang, et al.. (2015). Unstirred Water Layers and the Kinetics of Organic Cation Transport. Pharmaceutical Research. 32(9). 2937–2949. 16 indexed citations
11.
Morales, Mark, et al.. (2013). Substrate-Dependent Ligand Inhibition of the Human Organic Cation Transporter OCT2. Journal of Pharmacology and Experimental Therapeutics. 346(2). 300–310. 84 indexed citations
12.
Ekins, Sean, et al.. (2012). Molecular Determinants of Ligand Selectivity for the Human Multidrug and Toxin Extruder Proteins MATE1 and MATE2-K. Journal of Pharmacology and Experimental Therapeutics. 341(3). 743–755. 70 indexed citations
13.
Wunz, Theresa M., et al.. (2011). Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3). American Journal of Physiology-Renal Physiology. 301(2). F378–F386. 16 indexed citations
14.
Tatsumi, Ryuichi, Xiaosong Liu, Antonio J. Pérez‐Pulido, et al.. (2006). Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. American Journal of Physiology-Cell Physiology. 290(6). C1487–C1494. 153 indexed citations
15.
Groves, Carlotta E., Grażyna Nowak, & Mark Morales. (1999). Ochratoxin A Secretion in Primary Cultures of Rabbit Renal Proximal Tubule Cells. Journal of the American Society of Nephrology. 10(1). 13–20. 25 indexed citations
16.
Groves, Carlotta E. & Mark Morales. (1999). Chlorotrifluoroethylcysteine Interaction with Rabbit Proximal Tubule Cell Basolateral Membrane Organic Anion Transport and Apical Membrane Amino Acid Transport. Journal of Pharmacology and Experimental Therapeutics. 291(2). 555–561. 3 indexed citations
17.
Groves, Carlotta E., Mark Morales, & Stephen H. Wright. (1998). Peritubular Transport of Ochratoxin A in Rabbit Renal Proximal Tubules. Journal of Pharmacology and Experimental Therapeutics. 284(3). 943–948. 46 indexed citations
18.
Schmid, Franz X., Mark Morales, & Jaroslav Stark. (1995). Left ventricular outflow tract obstruction in TGA: Treatment with lv-to-pa valved conduit. The Annals of Thoracic Surgery. 59(1). 201–204. 4 indexed citations
19.
Groves, Carlotta E., Mark Morales, Alberto Gandolfi, William H. Dantzler, & Stephen H. Wright. (1995). Peritubular paraquat transport in isolated renal proximal tubules.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 926–932. 19 indexed citations
20.
Williams, Janet, et al.. (1994). Extracorporeal circulation in the management of severe tricyclic antidepressant overdose. The American Journal of Emergency Medicine. 12(4). 456–458. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fen Zhou Breakdown of academic impact, for papers by Pei Hu Breakdown of academic impact, for papers by Anne Wu Breakdown of academic impact, for papers by Zhu Zhou Breakdown of academic impact, for papers by Vladimír Semecký Breakdown of academic impact, for papers by Rucha Patel Breakdown of academic impact, for papers by Caroline Hild Hakvåg Pettersen Breakdown of academic impact, for papers by Salvatore Longo Breakdown of academic impact, for papers by Lisa Tee Breakdown of academic impact, for papers by J. R. Snyman
Rankless by CCL
2026